ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE:

18.03.2024

Alliance Healthcare UK entered into a new wholesale agreement with Opella Healthcare (T/A Sanofi Consumer Healthcare): February 2024

 

We are pleased to announce that, as of 01 February 2024, Alliance Healthcare UK has become one of the chosen wholesalers to supply Opella Healthcare’s (trading as Sanofi Consumer Healthcare) consumer healthcare products to all pharmacies in the United Kingdom.

 

Opella Healthcare’s consumer healthcare portfolio includes the brands Cialis®Together, Allevia®, Buscopan®Dulcolax® and Phenergan®.

 

Click here for full product details.

SUB-TYPE: CLASS 2 RECALL

class 2 recall-Sodiofolin 50 mg/ml, solution for injection/infusion 8ml

medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.

 

 

MHRA drug alert date:12/03/24

 

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-medac-gmbh-t-slash-a-medac-pharma-llp-sodiofolin-50-mg-slash-ml-solution-for-injection-slash-infusion-folinic-acid-400mg-slash-8ml-vial-el-24-a-slash-08?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b4b7a401-8a7a-4596-8818-f021b9fcd1d9&utm_content=immediately)

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE DO NOT STOCK

Sodiofolin 50 mg/ml, solution for injection/infusion 8ml

medac GmbH

E230320B

 

 

Further Information

For all medical enquiries, please contact medical information at medac Pharma LLP by email to info@medacpharma.co.uk or by telephone 01786 458086

SUB-TYPE:

Easter bank holiday opening hours 2024

 

To help keep our customers informed of changes to our service, we have published our Easter 2024 bank holiday opening hours for pharmacy and retail customers.

 

Easter 2024 bank holiday opening hours - England, Scotland, Wales and Northern Ireland

 

Easter 2024 bank holiday opening hours - Channel Islands and Isle of Man

SUB-TYPE:

UPDATE- Field Safety Notice- Viscopaste Bandage 4948 7.5CMX6M

This is an update to the previous field safety notice first distributed 21/12/23

 

A customer response form is being circulated, if you had received any affected stock please complete and return to the address listed: QA@evolan.se

 

We have received a Recall from EVOLAN PHARMA on VISCOPASTE BANDAGE 4948 7.5CMX6M

 

Date of recall: 21st December 2023

 

MHRA FSN Link: https://www.gov.uk/drug-device-alerts/field-safety-notices-fsns-from-18-to-22-december-2023

Pip code

Product description

Supplier

Batch Numbers

0332734

VISCOPASTE BNDG 4948 7.5CMX6M

EVOLAN PHARMA (MEDICAL)

D300381

 

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in use- Concerta XL tablets 18 &36mg

Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.

 

MHRA drug alert date: 26th February 2024

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-orifarm-uk-ltd-concerta-xl-18mg-and-36-mg-prolonged-release-tablets-el-24-a-slash-07?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a2016e58-88b6-4a8d-a1aa-ce9f9fa4bb23&utm_content=immediately

 

Pip code

Product

Supplier

Affected Batches

8436313

P.I CONCERTA XL TAB 18MG

Orifarm UK

3EE35801
3EE35802
3EE36101
3EE35803
3EE36102
3FE46100
3FE46101
3GE51900

8436370

P.I CONCERTA XL TAB 36MG

Orifarm UK

3AE07102 3GE50002
3DE29500
3FE44101
3FE44102
3AE07103
3DE29201
3DE29501
3FE44103
3FE46800
3FE46801
3EE37002

 

 

This is a caution in use only we are not accepting stock returns

 

 

Further Information

For medical information and stock control queries please email jacook@Orifarm.com, or telephone 01923 204333.

SUB-TYPE:

23.02.2024

South Normanton customer service centre welcomes Claire Ward

 

This week we welcomed Claire Ward, the mayoral candidate for the East Midlands, to our customer service centre in South Normanton and the Alloga UK Amber Park warehouse facility.


Claire met our Customer Service Agents to hear about the 1.5million customer conversations the team support each year, before meeting some of the 1,500 Alloga team members to learn more about the pre-wholesale business.


Claire also spent time with Marie Evans, Managing Director, Alliance Healthcare UK, who said: “It’s been wonderful to welcome Claire to the site and I’m delighted she had the opportunity to join our volunteering work in packing doctor packs full of essential medicines with International Health Partners today."

 

cww

SUB-TYPE: CLASS 2 RECALL

Class 2 recall- Adakveo 10mg/ml

Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion, batch number SJFN5, due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA. This is because the Phase III study (STAND) of Adakveo in sickle cell disease patients with vaso-occlusive crises did not confirm its clinical benefit. As a consequence, the conditional marketing authorisation in the UK is being revoked.

 

 

MHRA drug alert date:21/02/24

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-novartis-pharmaceuticals-uk-limited-adakveo-10-mg-slash-ml-concentrate-for-solution-for-infusion-el-24-a-slash-06?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5161cd08-b491-4965-a94e-03f1b56d8e4e&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE DO NOT STOCK

Adakveo 10 mg/ml

Novartis Pharmaceuticals UK Limited

SJFN5

 

 

Further Information

For medical information enquiries please contact Novartis Pharmaceuticals UK Limited at: https://www.novartis.com/uk-en/contact/contact-us, by email: medinfo.uk@novartis.com or via telephone: +44 1276 698370.

For stock control enquiries please contact: commercial.team@novartis.com

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

SUB-TYPE:

16.02.2024

Early detection paves the way for healthier futures: Highlights from AHUK’s Cancer Day Event

 

Alliance Healthcare UK recently hosted an impactful World Cancer Day Coffee morning, shining a light on the urgency and importance of early cancer detection. The event was marked by compelling discussions, heartfelt stories, and resilience against this global health challenge.

 

"Never, never, ever give up."

The event kicked off with Matt Addison, Operation Director at Alliance Healthcare UK, presenting key cancer statistics that underscored the importance of early detection. His opening speech was filled with inspiring messages of strength, determination, and hope. He shared powerful phrases like "What doesn't kill us makes us stronger", "I can, and I will", and "Never, never, ever give up". These words set a strong theme for the event: standing strong against cancer and how early detection can save lives.

 

Jackie Lewis: A pillar in pharmacy

Pharmacist Director, and valued Alliance Healthcare customer, Jackie Lewis, provided invaluable insights from her own journey with cancer. Owner of Lewis Pharmacy in Exmouth for 19 years and an Alphega Pharmacy member, she encourages community pharmacists to support their patients on the cancer pathway.

Jackie has developed ‘Let’s Communicate Cancer’, a comprehensive training package for pharmacy teams that has received national accreditation from NHS. In collaboration with Alliance Healthcare UK, she introduced ‘Not Normal for You’—a service designed to enable pharmacy staff to identify early stages of cancer in patients.

 

wcdt

 

Understanding cancer staging & trends

The importance of understanding cancer staging was highlighted during the event. With nearly half of all cancer cases diagnosed at stage 3 or 4—which is harder to treat—the goal set by NHS is to diagnose 75% of cancers at stage 1 or 2 by 2028.

 

38% of cancer cases are deemed preventable

With 38% of cancer cases deemed preventable, maintaining a healthy lifestyle was emphasised as crucial—non-smoking status, healthy weight management, nutritious eating habits, abstaining from alcohol consumption and sun safety are key preventive measures.

Regular screenings can help detect potential issues early; however, barriers such as embarrassment or fear often deter individuals from these important appointments—a concern discussed at length during the coffee morning.

 

Maximising opportunities within Pharmacy

Pharmacies are uniquely positioned to aid early detection—through over-the-counter conversations, consultations during vaccinations or simply asking about symptoms when customers buy medications. The 'Not Normal for You' service is one such initiative aimed at leveraging these opportunities for better patient outcomes.

 

“Cancer doesn't discriminate.”

Lee Garrett, National Account Manager – Hospitals, shared his personal experiences with cancer and the story of his friend Ben who has received 75 rounds of chemo and won’t stop until he beats Cancer.

His message was clear—if something doesn't feel right get it checked out without delay or embarrassment because "cancer doesn't discriminate". His recent challenge—to run 40 miles with family for Royal Marsden Charity—is a testament to showing support for those living with cancer and raising awareness of early detection.

 

Through hosting events like these and supporting patients via Alcura through their treatment process; Alliance Healthcare UK reaffirms its commitment towards creating healthier futures. This is more than just our purpose—it's a promise we live up to each day. United in our responsibility, we continue to take proactive steps forward in the battle against cancer, turning hope into action for a healthier tomorrow.

 

wc1  nnfy

SUB-TYPE: CLASS 3 RECALL

Class 3 recall-Ramipril 1.25mg tabs

Torrent Pharma (UK) Limited is recalling certain batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.

 

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-torrent-pharma-uk-limited-ramipril-1-dot-25mg-tablets-el-24-a-slash-05?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=37e221c3-75aa-46d3-ad81-abb2683aab40&utm_content=immediately

 

 

Pip code

Product Description

Affected Batches

1111681

RAMIPRIL TAB 1.25MG

(TORRENT PHARMA)

MG21264
MG21334
MG21335
MG221014
MG221016
MG23488
MG23489
MG23490
MG23729

6290688

 

RAMIPRIL TAB 1.25MG

(TORRENT PHARMA)

MG21264
MG21334
MG21335
MG221014
MG221016
MG23488
MG23489
MG23490
MG23729

 

Further Information

For medical information enquiries please contact APCER Life Sciences, via telephone: 0800 0885366, or email: Medinfo.Torrent@apcerls.com

For stock control enquiries please contact the Torrent Pharma (UK) Limited Customer Service & Sales Executive via telephone: 01293 574188,or email:  luke.davies@torrentpharma.co.uk  or priti.pragji@torrentpharma.co.uk

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

SUB-TYPE:

09.02.2024

Celebrating National Apprenticeship Week and the incredible impact apprenticeships have on individuals, businesses, and the economy

 

This week, we proudly celebrate our apprentices at Alliance Healthcare, including Karly Godber, Customer Care Coordinator. Since joining us in 2018, Karly has completed two apprenticeships and experienced remarkable growth due to her commitment to learning and development.

 

Karly shares her journey: "Starting as a Customer Service Advisor, I was determined to build a career within Alliance Healthcare. I seized every opportunity and enrolled in an apprenticeship to achieve Customer Services Level 2. It not only enhanced my confidence but also led to a promotion as Senior Advisor. The SWOT model I learned on the course really helped structure my interview answers."

 

kv2

 

Following this, I embarked on the Team Leader Level 3 course. Despite virtual workshops due to the pandemic, we learned extensive knowledge from leaders across various areas of the business. Within three months, I became a Team Manager and utilised my newfound skills during a challenging period of change."

 

Apprenticeships have not only given me more skills and confidence in my career path, but they have also provided development opportunities and progression at Alliance Healthcare. As a team manager, I've encouraged eight team members to pursue their own apprenticeships, resulting in improved service and overall customer experience!"

 

Karly has now recently joined the Area Customer Care Management team and we wish her the best of luck in her new role!